AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

6,013.00p
   
  • Change Today:
      75.00p
  • 52 Week High: 6,525.00
  • 52 Week Low: 5,182.00
  • Currency: UK Pounds
  • Shares Issued: 1,311.76m
  • Volume: 2,280,097
  • Market Cap: 78,876m
  • RiskGrade: 107

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 3.7% 3.5%
Div Cover 1.2 1.3
Op Mrgn 15.3% 23.5%
ROCE 103.5%  
Latest F'cast
P/E 22.0 22.1
PEG n/a n/a
Pr/Revenue 4.5 4.3
Pr/Book 7.1  
Latest F'cast
Revenue -1.7% -35.8%
PBT -10.5% 67.6%
EPS -19.2% -1.0%
DPS n/a -39.4%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 26,095.00 1,246.00 428.00¢ 13.5 n/a -15% 280.00¢ 4.9%
31-Dec-15 24,708.00 3,069.00 426.00¢ 13.7 n/a -0% 280.00¢ 4.8%
31-Dec-16 23,002.00 3,552.00 431.00¢ 13.0 13.0 +1% 280.00¢ 5.0%
31-Dec-17 22,465.00 2,227.00 428.00¢ 15.2 n/a -1% 280.00¢ 4.3%
31-Dec-18 22,090.00 1,993.00 346.00¢ 21.5 n/a -19% 280.00¢ 3.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 17,980.79 4,232.75 269.16p 22.3 n/a -1% 215.08p 3.5%
31-Dec-20 19,931.39 4,971.30 328.34p 18.3 0.8 +22% 217.41p 3.5%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Pooled analyses of the roxadustat global Phase III 10-May-2019 07:00 RNS
Director/PDMR Shareholding 08-May-2019 14:00 RNS
Director Declaration 08-May-2019 11:00 RNS

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
07-May-19 Buy Marc Dunoyer 5,800.00p 8,500 493,000.00
30-Apr-19 Buy Philip A J Broadley 5,738.00p 520 29,837.60
29-Apr-19 Buy Deborah DiSanzo 5,923.47p 500 29,617.35

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 6,013.00p
Change Today 75.00p
% Change 1.26 %
52 Week High 6,525.00
52 Week Low 5,182.00
Volume 2,280,097
Shares Issued 1,311.76m
Market Cap 78,876m
RiskGrade 107

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.65% below the market average50.65% below the market average50.65% below the market average50.65% below the market average50.65% below the market average
41.38% above the sector average41.38% above the sector average41.38% above the sector average41.38% above the sector average41.38% above the sector average
Price Trend
47.38% above the market average47.38% above the market average47.38% above the market average47.38% above the market average47.38% above the market average
44.26% above the sector average44.26% above the sector average44.26% above the sector average44.26% above the sector average44.26% above the sector average
Income
1.75% below the market average1.75% below the market average1.75% below the market average1.75% below the market average1.75% below the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Growth
94.6% below the market average94.6% below the market average94.6% below the market average94.6% below the market average94.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 16
Buy 0
Neutral 8
Sell 1
Strong Sell 3
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-19 28-Feb-19
Paid 09-Sep-19 27-Mar-19
Amount 90.00¢ 190.00¢

Trades for 23-May-2019

Time Volume / Share Price
17:12 13,343 @ 6,052.98p
16:42 25,000 @ 6,016.23p
16:36 236 @ 6,013.00p
16:36 264 @ 6,013.00p
16:36 236 @ 6,013.00p

Top of Page